All News

Novel approach may improve efficacy of pancreatic cancer treatments.

Breast microbiome may be harnessed to treat the development of breast cancer.

Gilead's experimental combination therapy observed to reduce HIV RNA in adult patients.

Tools that analyze the cancer genome provide new insight into the mechanisms that drive cancer development.

Sink your teeth into these 5 ways that sharks could benefit humans, potentially leading to new drug developments.

Top news of the day from across the healthcare landscape.

Top news of the day from across the health care landscape.

The demand for innovation is not slowing down. 

Although many of Heather’s clients enjoy taking care of patients, she has observed that recent changes in the practice of medicine are leading to increased burnout rates among physicians.

Combination treatments well tolerated amongst study participants with HIV-1 infection.

Pharmacists with a collaborative practice agreement in place will play a larger role in the healthcare delivery team.

Women who have no signs or symptoms of ovarian cancer should not receive a screening, according to a draft recommendation statement from the US Preventive Services Task Force (USPSTF).

The National Diabetes Statistics Report found that 1 in 4 patients are unaware they have diabetes.

Proper dosing of Vorinostat can help expose latent HIV.

When cancerous cells die, they instruct neighboring cells to replace them.

The FDA has granted tentative approval to Merck's Lusduna Nexvue (insulin glargine injection) 100 units/mL. The drug is a follow-on biologic basal insulin for patients with type 2 diabetes and is administered through a pre-filled dosing device, according to a press release.

Belimumab (Benlysta) in a subcutaneous treatment for active, autoantibody-positive systemic lupus erythematosus.

Memory T cell subtypes can be reactivated with current immunotherapy.

Subcutaneous belimumab (Benlysta) is a human monoclonal antibody that treats active, autoantibody-positive systemic lupus erythematosus.

Lusduna Nexvue insulin glargine injection is a follow-on biologic for patients with type 2 diabetes.

Sanofi lawsuit delays emergence of follow-on biologic of insulin glargine injection for type 2 diabetes.

Top news of the day from across the healthcare landscape.

Top news of the day from across the health care landscape.

Renflexis is indicated for the same inflammatory conditions as reference drug infliximab.

Renflexis is a biosimilar of Remicade, which treats inflammatory conditions, including Crohn’s disease, rheumatoid arthritis, and psoriatic arthritis.

Generic drug prescribing and use continues to trend upward in workers compensation, according to a report recently released by Coventry Workers Comp Services. Generic drug prescribing and use continues to trend upward in workers compensation, according to a report recently released by Coventry Workers Comp Services.

This article contains a great snapshot into U-500 education to further your knowledge and promote patient safety.

Pharmacists have a great responsibility to stay current with the laws and regulations governing the profession.

We will explore some common herbal remedies for hangover symptoms and consider the peer-reviewed evidence behind their use.

We spoke with him to find out how he got the idea for the site, how it works and what his plans are for the future.